Literature DB >> 11135256

Anatomical evidence for presynaptic modulation by the delta opioid receptor in the ventrolateral periaqueductal gray of the rat.

K G Commons1, S G Beck, C Rudoy, E J Van Bockstaele.   

Abstract

The delta opioid receptor (DOR) modulates nociception and blood pressure in the periaqueductal gray (PAG). To examine the cellular basis for DOR effects, the ultrastructural distribution of DOR immunoreactivity was examined in the caudal ventrolateral PAG. DOR immunoreactivity was located predominantly in axon terminals that formed asymmetric (excitatory-type) synaptic contacts. However, rather then localized to the plasma membrane of synaptic boutons, immunolabeling for the DOR was intracellular, often associated with large dense-core vesicles. This finding suggests that dense-core vesicles may play a role in targeting the DOR, as vesicle fusion would shift the distribution of the DOR to the plasma membrane. To investigate the neural circuits in which DOR may function, dual-immunolabeling was used to determine the relationship of the DOR to an endogenous ligand, enkephalin, and to a potential target, GABAergic neurons. Approximately a third (38 of 127) of DOR containing axons had enkephalin immunoreactivity, indicating DOR may act in part as a presynaptic autoreceptor. Although single axon terminals containing immunoreactivity for both DOR and GABA were not detected, some DOR-immunolabeled axon terminals (26 of 86) contacted soma or dendrites containing GABA. These data suggest that the DOR may act in part as an autoreceptor to regulate synaptic input to GABAergic as well as non-GABAergic PAG neurons. Furthermore, the exposure of the DOR to the extracellular space may be contingent upon dense-core vesicle fusion with the plasma membrane. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135256

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  14 in total

1.  Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.

Authors:  Tara A Macey; Erin N Bobeck; Deborah M Hegarty; Sue A Aicher; Susan L Ingram; Michael M Morgan
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

Review 2.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 3.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 4.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

5.  Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Authors:  Stephen P Hack; Elena E Bagley; Billy C H Chieng; MacDonald J Christie
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

6.  Role of endogenous sleep-wake and analgesic systems in anesthesia.

Authors:  Jun Lu; Laura E Nelson; Nick Franks; Mervyn Maze; Nancy L Chamberlin; Clifford B Saper
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

7.  Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens.

Authors:  Lisa M Ambrose-Lanci; Niluk B Peiris; Ellen M Unterwald; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2008-03-15       Impact factor: 3.252

Review 8.  High resolution approaches for the identification of amyloid fragments in brain.

Authors:  J A Ross; P M Mathews; E J Van Bockstaele
Journal:  J Neurosci Methods       Date:  2018-10-24       Impact factor: 2.390

9.  Localization of endogenous amyloid-β to the coeruleo-cortical pathway: consequences of noradrenergic depletion.

Authors:  Jennifer A Ross; Beverly A S Reyes; Steven A Thomas; Elisabeth J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2017-08-04       Impact factor: 3.748

Review 10.  Trafficking of central opioid receptors and descending pain inhibition.

Authors:  Bihua Bie; Zhizhong Z Pan
Journal:  Mol Pain       Date:  2007-12-04       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.